Radiotherapy in non-small cell lung cancer: optimal doses and schedules.
The doses and schedules for radiation therapy as applied in Stages IIIB and IIIA non-small cell lung cancer patients show a great variety. Depending on its intent, several purely palliative schemes can be used. When a curative intent scheme is considered, patients can be treated with a more experimental approach as several options are tested to increase selectively the radiation dose in the tumour areas. If improvements in treatment schemes are proven, new standards can be set.
Schaake-Koning
C
C
The Netherlands Cancer Institute, Antoni van Leeuwenhoek Huis, Amsterdam.
D002289:Carcinoma, Non-Small-Cell Lung / Q000532:radiotherapy*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D008175:Lung Neoplasms / Q000532:radiotherapy*; D010166:Palliative Care; D011879:Radiotherapy Dosage